Sevoflurane Inhibits Proliferation and Invasion of Human Ovarian Cancer Cells by Regulating JNK and p38 MAPK Signaling Pathway

References

• Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177(3):1053–1064. doi:10.2353/ajpath.2010.10010520651229
   PubMed Web of Science ®Google Scholar
• Jayson GC, Kohn EC, Kitchener HC, et al. Ovarian cancer. Lancet. 2014;384(9951):1376–1388. doi:10.1016/S0140-6736(13)62146-724767708
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. doi:10.3322/caac.2133226742998
   PubMed Web of Science ®Google Scholar
• Matulonis UA, Sood AK, Fallowfield L, et al. Ovarian cancer. Nat Rev Dis Primers. 2016;2:16061. doi:10.1038/nrdp.2016.6127558151
   PubMed Web of Science ®Google Scholar
• Berek JS, Kehoe ST, Kumar L, et al. Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynecol Obstetr. 2018;143:59–78. doi:10.1002/ijgo.12614
   PubMed Web of Science ®Google Scholar
• Coleman RL, Monk BJ, Sood AK, et al. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol. 2013;10(4):211. doi:10.1038/nrclinonc.2013.523381004
   PubMed Web of Science ®Google Scholar
• Deng L, Wang Y, Lu W, et al. Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report. Onco Targets Ther. 2017;10:1521. doi:10.2147/OTT.S12647128352185
   PubMed Web of Science ®Google Scholar
• Gray H, Benigno B, Berek J, et al. Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized Phase 2 trial. J Immunother Cancer. 2016;4(1):34. doi:10.1186/s40425-016-0137-x27330807
   PubMed Web of Science ®Google Scholar
• Fenglian X, Degn F, Long Y, et al. Clinical effect of sevoflurane and propofol anesthesia on hemorrheology in elderly patients with colon cancer radical surgery. Chin J Biochem Pharm. 2017;37(3):240–242.
   Google Scholar
• Oh C-S, Lee J, Yoon T-G, et al. Effect of equipotent doses of propofol versus sevoflurane anesthesia on regulatory T cells after breast cancer surgery. Anesthesiology. 2018;129(5):921–931. doi:10.1097/ALN.000000000000238230074934
   PubMed Web of Science ®Google Scholar
• Wang L, Wang T, Gu J-Q, et al. Volatile anesthetic sevoflurane suppresses lung cancer cells and miRNA interference in lung cancer cells. Onco Targets Ther. 2018;11:5689. doi:10.2147/OTT.S17167230254461
   PubMed Web of Science ®Google Scholar
• Ding J, Zhang L, Zeng S, et al. Clinically relevant concentration of sevoflurane suppresses cervical cancer growth and migration through targeting multiple oncogenic pathways. Biochem Biophys Res Commun. 2019. doi:10.1016/j.bbrc.2019.05.082
   Web of Science ®Google Scholar
• Gao C, Shen J, Meng Z-X, et al. Sevoflurane inhibits glioma cells proliferation and metastasis through miRNA-124-3p/ROCK1 axis. Pathol Oncol Res. 2019;1–8.28924964
   PubMed Web of Science ®Google Scholar
• Yang X, Zheng YT, Rong W. Sevoflurane induces apoptosis and inhibits the growth and motility of colon cancer in vitro and in vivo via inactivating Ras/Raf/MEK/ERK signaling. Life Sci. 2019;116916.31626792
   PubMed Web of Science ®Google Scholar
• Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. doi:10.3322/caac.2120824399786
   PubMed Web of Science ®Google Scholar
• Narod S. Can advanced-stage ovarian cancer be cured? Nat Rev Clin Oncol. 2016;13(4):255. doi:10.1038/nrclinonc.2015.22426787282
   PubMed Web of Science ®Google Scholar
• Flanagan JM, Wilson A, Koo C, et al. Platinum-based chemotherapy induces methylation changes in blood DNA associated with overall survival in patients with ovarian cancer. Clin Cancer Res. 2017;23(9):2213–2222. doi:10.1158/1078-0432.CCR-16-175427663594
   PubMed Web of Science ®Google Scholar
• Deraco M, Kusamura S, Virzì S, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial. Gynecol Oncol. 2011;122(2):215–220. doi:10.1016/j.ygyno.2011.05.00421665254
   PubMed Web of Science ®Google Scholar
• Zou S, Cao N, Cheng D, et al. Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin. Int J Nanomedicine. 2012;7:3823. doi:10.2147/IJN.S3063122888237
   PubMed Web of Science ®Google Scholar
• Fu Y, Zhang Q, Wang X, et al. Antidiabetic drug metformin mitigates ovarian cancer SKOV3 cell growth by triggering G2/M cell cycle arrest and inhibition of m-TOR/PI3K/Akt signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(5):1169–1175.28338172
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang S, Chan HF, et al. Dihydromyricetin induces apoptosis and reverses drug resistance in ovarian cancer cells by p53-mediated downregulation of survivin. Sci Rep. 2017;7:46060. doi:10.1038/srep4606028436480
   PubMed Web of Science ®Google Scholar
• Rhondali O, Pouyau A, Mahr A, et al. Sevoflurane anesthesia and brain perfusion. Pediatr Anesth. 2015;25(2):180–185. doi:10.1111/pan.2015.25.issue-2
   PubMed Web of Science ®Google Scholar
• Liu J, Yang L, Guo X, et al. Sevoflurane suppresses proliferation by upregulating microRNA-203 in breast cancer cells. Mol Med Rep. 2018;18(1):455–460. doi:10.3892/mmr.2018.894929750301
   PubMed Web of Science ®Google Scholar
• Yang Y, Hu R, Yan J, et al. Sevoflurane inhibits the malignant potential of head and neck squamous cell carcinoma via activating the hypoxia‑inducible factor-1α signaling pathway in vitro. Int J Mol Med. 2018;41(2):995–1002. doi:10.3892/ijmm.2017.330629207062
   PubMed Web of Science ®Google Scholar
• Liang H, Gu M-N, Yang C-X. Sevoflurane inhibits proliferation, induces apoptosis, and blocks cell cycle progression of lung carcinoma cells. Asian Pac j Cancer Prev. 2011;12(12):3415–3420.22471490
   PubMedGoogle Scholar
• Iwasaki M, Zhao H, Jaffer T, et al. Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells. Oncotarget. 2016;7(18):26042. doi:10.18632/oncotarget.v7i1827028996
   PubMedGoogle Scholar
• Choe KN, Moldovan GL. Forging ahead through darkness: PCNA, still the principal conductor at the replication fork. Mol Cell. 2017;65(3):380–392. doi:10.1016/j.molcel.2016.12.02028157503
   PubMed Web of Science ®Google Scholar
• Pu X, Storr SJ, Zhang Y, et al. Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival. Apoptosis. 2017;22(3):1–12. doi:10.1007/s10495-016-1323-527815720
   PubMed Web of Science ®Google Scholar
• Xu Y, Qin L, Sun T, et al. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression. Oncogene. 2017;36(8):1157–1166. doi:10.1038/onc.2016.28627524420
   PubMed Web of Science ®Google Scholar
• Olaso E, Ikeda K, Eng FJ, et al. DDR2 receptor promotes MMP-2–mediated proliferation and invasion by hepatic stellate cells. J Clin Invest. 2001;108(9):1369. doi:10.1172/JCI20011237311696582
   PubMed Web of Science ®Google Scholar
• Ramos-Desimone N, Hahn-Dantona E, Sipley J, et al. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem. 1999;274(19):13066–13076. doi:10.1074/jbc.274.19.1306610224058
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu W-Z, Liu T, et al. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Sig Transd. 2015;35(6):600–604. doi:10.3109/10799893.2015.1030412
   PubMed Web of Science ®Google Scholar
• You Z, Liu SP, Du J, et al. Advancements in MAPK signaling pathways and MAPK‐targeted therapies for ameloblastoma: a review. J Oral Pathol Med. 2019;48(3):201–205. doi:10.1111/jop.1280730489659
   PubMed Web of Science ®Google Scholar
• Wang S, Wang M, Wang M, et al. Bavachinin induces oxidative damage in HepaRG cells through p38/JNK MAPK pathways. Toxins. 2018;10(4):154. doi:10.3390/toxins10040154
   PubMed Web of Science ®Google Scholar